In addition, we found that knockdown of EGFR and CLPTM1L expression significantly inhibited migration and invasion, whereas knockdown of ATP9B or PQLC1 significantly enhanced migration and invasion of cancer cells (Fig. 3c and Supplementary Figs 18–20). The gene discussed is EGFR; the disease is cancer.